Blog - Page 583 of 5695 - QualityStocks

MondayJan 08, 2024 9:45 am

Turbo Energy (NASDAQ: TURB) Strategically Positioned for Growth in the Age of Artificial Intelligence

Despite challenges in the self-consumption photovoltaic sector, Turbo Energy achieved remarkable milestones, including the launch of the SunBox Industry product line, securing a patent, and forming strategic partnerships The company raised $5 million through its American Depositary Shares on the Nasdaq Capital Market, demonstrating its financial prowess amid industry headwinds Despite industry challenges, Turbo Energy maintains an optimistic outlook, leveraging diverse product offerings based on AI-driven energy optimization In the midst of challenges faced by the self-consumption photovoltaic sector in 2023, Turbo Energy (NASDAQ: TURB), a Spain-based photovoltaic energy storage innovator, achieved notable achievements. Despite revenue decline due to headwinds…

MondayJan 08, 2024 9:00 am

Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’

Sigyn Therapeutics in May 2023 announced patent and trademark applications for its ImmunePrep commercialization platform In October 2022, the company announced patent and trademark applications for ChemoPrep and ChemoPure to enhance chemotherapy and reduce toxicity Sigyn Therapeutics in September 2022 announced plans to conduct first-in-human feasibility studies in end-stage renal disease patients In August 2022, the company commenced trading on the OTCQB Venture Market Sigyn Therapeutics (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. The company’s therapeutic candidates include Sigyn Therapy(TM) to address pathogen-associated inflammatory disorders, the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic…

FridayJan 05, 2024 11:55 am

QualityStocksNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Recaps Successful Year, Eyes Robust 2024 Development Plans

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) has announced that 2023 was a highly successful year for the restructured company. Among the highlights, PEI reportedly drilled, completed and tied-in nine horizontal wells in heavy oil reservoir with initial production rates exceeding expectations at 100+bpd per well. The ninth well was rig released on Dec. 24 and was brought online on Dec. 28. Prospera also drilled a directional well accessing medium-light oil flowing at 500+ Bpd. The company attained gross peak rates of 1,800 boepd prior to year-end, excluding the production of the recently drilled and completed horizontals, and the shut-in…

FridayJan 05, 2024 11:15 am

How Next-Gen Investors Are Maximizing the Value of Microcap Conferences

Microcap conferences have transformed to adapt to the needs of tech-focused investors Digital platforms have expanded the reach of microcap conferences to provide real-time updates, company profiles, and interactive features for enhanced research and networking Investors can maximize the value of microcap conferences by prioritizing key agenda items and creating a schedule that aligns with their goals Physical events are back and better than ever, set against the backdrop of exciting locations and featuring a variety of social events and activities Picture the investment events of the past: the drab conference rooms, coffee cups that were too small, heavy binders…

FridayJan 05, 2024 11:02 am

QualityStocksNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces Participation in Upcoming iAccess Alpha Virtual MicroCap Conference

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, will be represented at next week’s iAccess Alpha Virtual MicroCap Conference. The two-day, online event will be held Jan. 9–10, 2024. According to the announcement, DoubleDown Interactive CFO Joe Sigrist will attend the conference and is also scheduled to present. His presentation will begin at 2:30 p.m. ET on Jan. 9. In addition, Sigrist will be available for one-on-one meetings with institutional investors throughout the event. A replay of the webcast will be available on the company’s website. To view the live presentation,…

FridayJan 05, 2024 10:30 am

Electronic Servitor Publication Network Inc. (XESP) Finalizes PhiTech Management, LLC Asset Purchase Including Proprietary Digital Engagement Engine(TM)

The Digital Engagement Engine(TM) allows companies to maintain complete control of their content while creating meaningful relationships with new customers and revenue streams XESP focuses on three important digital elements to improve client outcomes – connecting with the audience, relating to the community, and influencing positive customer relationships XESP plans to expand business development planning and communications through channel partners and consultants, and fully engage in efforts to create rapid expansion and adoption of its managed service product across multiple verticals Electronic Servitor Publication Network (OTCQB: XESP), a digital engagement company, recently announced the finalization of its purchase of assets…

FridayJan 05, 2024 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Commends and Supports U.S. Policymakers for the National Defense Authorization Act

National Defense Authorization Act (“NDAA”) signed into law on December 22, 2023 NDAA includes quantum pilot program dedicated to near-term quantum computing applications, which D-Wave has already been developing, and calls for consideration of all quantum technologies (annealing, hybrid and gate model) Legislation promotes cultivating and strengthening relationships between the Department of Defense, academic institutions, small enterprises, and unconventional defense contractors D-Wave Quantum (NYSE: QBTS), the world's first commercial supplier of quantum computers, software, and services, commends U.S. policymakers for including a groundbreaking quantum pilot program, dedicated to near-term quantum computing applications, as part of the National Defense Authorization Act…

FridayJan 05, 2024 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) the West’s Strategy to Weaken China’s Minerals Dominance with its RapidSX(TM) Technology

Ucore, a company engaged in the exploration for and separation and scalable production of REEs in Canada and the US, is in the process of perfecting and ultimately commercializing the separation and purification of critical metals This is in a move to slash reliance on Chinese rare earths technologies and its toxic by-products The company has made incredible headway over the years and is on track to commercially separate U.S.-friendly sources of REES, using its RapidSX(TM) technology, by 2025 The commissioning of its RapidSX Demonstration plant in Kingston, Ontario, earlier this year affirms its commitment to actualizing the goal of…

ThursdayJan 04, 2024 2:51 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Invoices $12M-Plus for Class 1, Class 3 EVs in 2023

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on the status of its Class 1 and Class 3 vehicles for 2023. According to the announcement, the company delivered 100 Class 1 and 141 Class 3 vehicles by year end, for a total invoiced amount of $12,559,520. Mullen also anticipates delivering an additional 185 Class 1 vehicles by Jan. 8, 2024. The vehicles were delivered to the Randy Marion Automotive Group as part of a vehicle purchase order calling for 6,000 Class 1 vehicles and 1,000 Class 3 vehicles in total; invoicing for the vehicles will total…

ThursdayJan 04, 2024 2:22 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of Rybelsus(R)-Branded GLP-1 Drug Semaglutide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced positive final results from its recently completed human Pilot Study #1 evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide available commercially in the branded product Rybelsus(R). According to the announcement, the study was performed by a prominent university research center comparing a single 7 mg semaglutide dose of a Rybelsus tablet (“control”) to a matching dose from Rybelsus that had been compound formulated in capsule form using DehydraTECH processing technology enhancements (“DehydraTECH GLP-1”). In general, the DehydraTECH processing enabled improvements…

Site Search

Company Search